174 related articles for article (PubMed ID: 23024794)
1. Evaluation of a novel assay for detection of the fetal marker RASSF1A: facilitating improved diagnostic reliability of noninvasive prenatal diagnosis.
White HE; Dent CL; Hall VJ; Crolla JA; Chitty LS
PLoS One; 2012; 7(9):e45073. PubMed ID: 23024794
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis.
Chan KC; Ding C; Gerovassili A; Yeung SW; Chiu RW; Leung TN; Lau TK; Chim SS; Chung GT; Nicolaides KH; Lo YM
Clin Chem; 2006 Dec; 52(12):2211-8. PubMed ID: 17068167
[TBL] [Abstract][Full Text] [Related]
3. Early non-invasive detection of fetal Y chromosome sequences in maternal plasma using multiplex PCR.
Kolialexi A; Tounta G; Apostolou P; Vrettou C; Papantoniou N; Kanavakis E; Antsaklis A; Mavrou A
Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):34-7. PubMed ID: 22261468
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma--next step toward reliable non-invasive prenatal diagnostics.
Zejskova L; Jancuskova T; Kotlabova K; Doucha J; Hromadnikova I
Exp Mol Pathol; 2010 Dec; 89(3):241-7. PubMed ID: 20868679
[TBL] [Abstract][Full Text] [Related]
5. [Detection of fetal RASSF1A gene in maternal plasma for noninvasive prenatal diagnosis].
Ma L; Liu YC; Zheng L; Wu MH; Liu Y; Sun J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1301-4. PubMed ID: 24156454
[TBL] [Abstract][Full Text] [Related]
6. Fetal-specific hypermethylated RASSF1A quantification in pregnancy.
Saraswathy S; Sahai K; Arora D; Krishnan M; Mendiratta SL; Biswas S; Abraham KM
J Matern Fetal Neonatal Med; 2017 Apr; 30(7):849-853. PubMed ID: 27165812
[TBL] [Abstract][Full Text] [Related]
7. Application of real-time PCR of sex-independent insertion-deletion polymorphisms to determine fetal sex using cell-free fetal DNA from maternal plasma.
Ho SS; Barrett A; Thadani H; Asibal CL; Koay ES; Choolani M
Clin Chem Lab Med; 2015 Jul; 53(8):1189-95. PubMed ID: 25581758
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of fetal hypermethylated RASSF1A in pre-eclampsia and its relationship with placental protein-13, pregnancy associated plasma protein-A and urine protein.
Saraswathy S; Sahai K; Yadav TP; Arora D; Mendiratta SL; Naqvi SH; Biswas S; Krishnan M; Abraham KM
Pregnancy Hypertens; 2016 Oct; 6(4):306-312. PubMed ID: 27939474
[TBL] [Abstract][Full Text] [Related]
9. Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma.
van den Oever JM; Balkassmi S; Segboer T; Verweij EJ; van der Velden PA; Oepkes D; Bakker E; Boon EM
PLoS One; 2013; 8(12):e84051. PubMed ID: 24391879
[TBL] [Abstract][Full Text] [Related]
10. Dynamic Changes of Fetal-Derived Hypermethylated RASSF1A and Septin 9 Sequences in Maternal Plasma.
Zhang L; Wang CM; Zhou WP; Chen QP; Zhou S; Lei W; Deng H; Zhang L; Liu GC
Reprod Sci; 2021 Apr; 28(4):1194-1199. PubMed ID: 33417202
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Diagnosis of Fetal Gender: Utility of Combining DYS14 and SRY.
Jacob RR; Saxena R; Verma IC
Genet Test Mol Biomarkers; 2015 Sep; 19(9):505-11. PubMed ID: 26121024
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma.
Zhang M; Li T; Chen J; Li L; Zhou C; Wang Y; Liu W; Zhang Y
J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):687. PubMed ID: 22038362
[TBL] [Abstract][Full Text] [Related]
13. RASSF1A in maternal plasma as a molecular marker of preeclampsia.
Papantoniou N; Bagiokos V; Agiannitopoulos K; Kolialexi A; Destouni A; Tounta G; Kanavakis E; Antsaklis A; Mavrou A
Prenat Diagn; 2013 Jul; 33(7):682-7. PubMed ID: 23526657
[TBL] [Abstract][Full Text] [Related]
14. Detection of restriction enzyme-digested target DNA by PCR amplification using a stem-loop primer: application to the detection of hypomethylated fetal DNA in maternal plasma.
Tong YK; Chiu RW; Leung TY; Ding C; Lau TK; Leung TN; Lo YM
Clin Chem; 2007 Nov; 53(11):1906-14. PubMed ID: 17901110
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive fetal sex determination in maternal plasma: a prospective feasibility study.
Fernández-Martínez FJ; Galindo A; Garcia-Burguillo A; Vargas-Gallego C; Nogués N; Moreno-García M; Moreno-Izquierdo A
Genet Med; 2012 Jan; 14(1):101-6. PubMed ID: 22237438
[TBL] [Abstract][Full Text] [Related]
16. Cell-Free RNA Is a Reliable Fetoplacental Marker in Noninvasive Fetal Sex Determination.
Mersy E; Faas BH; Spierts S; Houben LM; Macville MV; Frints SG; Paulussen AD; Veltman JA
Clin Chem; 2015 Dec; 61(12):1515-23. PubMed ID: 26467504
[TBL] [Abstract][Full Text] [Related]
17. Quantification of extracellular DNA using hypermethylated RASSF1A, SRY, and GLO sequences--evaluation of diagnostic possibilities for predicting placental insufficiency.
Hromadnikova I; Zejskova L; Kotlabova K; Jancuskova T; Doucha J; Dlouha K; Krofta L; Jirasek JE; Vlk R
DNA Cell Biol; 2010 Jun; 29(6):295-301. PubMed ID: 20235876
[TBL] [Abstract][Full Text] [Related]
18. Early fetal gender determination using real-time PCR analysis of cell-free fetal DNA during 6th-10th weeks of gestation.
Khorram Khorshid HR; Zargari M; Sadeghi MR; Edallatkhah H; Shahhosseiny MH; Kamali K
Acta Med Iran; 2013 May; 51(4):209-14. PubMed ID: 23690098
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive prenatal determination of fetal sex: translating research into clinical practice.
Hill M; Finning K; Martin P; Hogg J; Meaney C; Norbury G; Daniels G; Chitty LS
Clin Genet; 2011 Jul; 80(1):68-75. PubMed ID: 20840219
[TBL] [Abstract][Full Text] [Related]
20. Use of free fetal DNA in prenatal noninvasive detection of fetal RhD status and fetal gender by molecular analysis of maternal plasma.
Sedrak M; Hashad D; Adel H; Azzam A; Elbeltagy N
Genet Test Mol Biomarkers; 2011 Sep; 15(9):627-31. PubMed ID: 21488716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
